Glonghui, May 23 | Irish medical device company Medtronic announced results for the fourth fiscal quarter ending April 26. Adjusted earnings per share were $1.46, lower than $1.57 in the same period last year, but slightly higher than analysts' expectations of $1.45. Despite facing foreign exchange headwinds of $72 million, revenue increased slightly by 0.5% to $8.59 billion, higher than analysts' expectations of $8.44 billion. Medtronic expects adjusted earnings per share for fiscal year 2025 to be between $5.4 and $5.5. Based on current interest rates, foreign currencies will have a negative impact of 5%. Medtronic executives said revenue growth in emerging markets has been unstable over the past few years, but these fundamentals are returning.